Worldwide Point-of-care Testing (POCT) Market Forecasting CAGR of +9.5% From 2017 to 2024 By Product, Application, Industry, End User, Growth, Key Vendors and Geography

Point-of-care Testing (POCT) Market report provides in-depth statistics and analysis available on the market status of the POCT Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the point of care testing market Industry.

Avail 10% Discount on Direct Purchase "Global Point-of-Care Testing Market" Or kindly send the email at sopan.gedam@databridgemarketresearch.com

Data Bridge Market Research new Insight’s on “Global Point-of-Care Testing (POCT) Market is projected to reach 38.2 billion by 2024, from USD 18.5 billion in 2016 growing at a CAGR of 9.5% during the forecast period of 2017 to 2024”.

Request and Click Here for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

Recent Developments

The demand for point-of-care testing (POCT) is growing due to the value-shift in healthcare and increasing technological advancements. Also, the rising prevalence of lifestyle and infectious diseases, early detection of diseases, and management of multiple chronic conditions is fueling the growth of the market. Some of the other factors contributing to the growth of the market are Private investments and venture funding, new product development and government support, increasing adoption of POC devices, and miniaturization of devices. On the other hand, factors such as pricing pressure, low reimbursement, and XX are restraining the growth of the market.

Segmentation
The global point-of-care testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance, in June 2015, Roche launched its Cardiac point-of-care (POC) troponin test for the cobas h 232 system which is available for countries which accept the CE Mark. This product has improved accuracy at low concentrations and it will help in diagnosis of heart attack patients with high mortality risk. The report includes company share data for different geographies including Global, North America, Europe and APAC.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Any specific requirements are you looking for? Ask to your Industry Experts@: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

Some Key Players:

Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedicaamong others holds 53.1% of the global injectable drug delivery market in 2016.

F. HOFFMANN-LA ROCHE LTD:

Historical Background – Roche was established in 1896
Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.

Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.
Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

Any specific requirements are you looking for? Ask to your Industry Experts: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market

LIST OF TABLE GLOBAL POINT-OF-CARE TESTING MARKET

TABLE 1 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES

TABLE 2 GLOBAL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 3 GLOBAL CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 4 GLOBAL INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 5 GLOBAL CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 6 GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)

TABLE 7 DISTRIBUTION CHANNEL, DIRECT TENDER, BY REGION, 2015 – 2024 (USD MILLION)

TABLE 8 DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY REGION, 2015 – 2024 (USD MILLION)

TABLE 9 GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 10 GLOBAL POINT-OF-CARE TESTING MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION)

TABLE 11 GLOBAL POINT-OF-CARE TESTING MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION)

TABLE 12 GLOBAL POINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY REGION 2015– 2024 (USD MILLION)

TABLE 13 GLOBAL POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY REGION 2015– 2024 (USD MILLION)

TABLE 14 GLOBAL POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY REGION 2015– 2024 (USD MILLION)

TABLE 15 GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION)

TABLE 16 GLOBAL POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)

TABLE 17 GLOBAL POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)

TABLE 18 GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION)

TABLE 19 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)

TABLE 20 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 21 NORTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

TABLE 22 NORTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)

TABLE 23 NORTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)

TABLE 24 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)

TABLE 25 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 26 NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

TABLE 27 U.S.POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)

TABLE 28 U.S. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)

TABLE 29 U.S. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)

TABLE 30 U.S. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

Read more about the Global Point-of-Care Testing (POCT) Market Report Visit @ http://databridgemarketresearch.com/reports/point-care-testing-poct-market/

Other Market Insights:

The Global Molecular Spectroscopy Market, latest insights by Data Bridge Market Research states that the market is growing at CAGR of 5.0% in the forecast period 2017 to 2024, expected to reach USD 6.712 Billion by 2024.

Report Access: http://databridgemarketresearch.com/reports/global-molecular-spectroscopy-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.